Neutral on Johnson & Johnson (JNJ) as of 2026-10-24.
Johnson & Johnson remains an exceptional healthcare franchise, but $264 offers no demonstrated Buffett-style margin of safety. Its 24.5% ROIC, 67.9% gross margin, research infrastructure, regulatory expertise, and MedTech switching costs support durable earning power. The principal risk is not insolvency or temporary volatility—it is overpaying for earnings normalization and growth that have not yet been verified in free cash flow.
Full open-source research report: https://research.deepvalues.ai/company/jnj/2026-10-13-en/?utm_source=podcast&utm_medium=description&utm_campaign=dvi&utm_content=jnj
Chapters
(0:00) Three tests for ownership
(0:11) Medicine leads, MedTech diversifies
(1:05) Patents and switching costs endure
(2:23) Revenue rises, cash flow wobbles
(4:00) Returns strong, multiple elevated
(5:15) Price demands exceptional growth
(6:33) Quality passes, valuation fails
(7:19) Price or growth changes view
Tools
DeepValues app (iOS): https://apps.apple.com/us/app/deepvalues/id6775568608
Track whether the market is overvalued:
Buffett Indicator (iOS): https://apps.apple.com/us/app/buffett-indicator/id6747404614
Bubble Watch (Android): https://play.google.com/store/apps/details?id=com.luluventures.buffett&referrer=utm_source%3Dpodcast%26utm_medium%3Ddescription%26utm_campaign%3Ddvi
Open-source research: https://research.deepvalues.ai/?utm_source=podcast&utm_medium=description&utm_campaign=dvi&utm_content=jnj
Run your own analysis at deepvalues.ai: https://deepvalues.ai/?ref=podcast&src=episode&utm_source=podcast&utm_medium=description&utm_campaign=dvi&utm_content=jnj
All our podcasts: https://podcasts.apple.com/us/channel/deepvalues/id6826606342
API for developers and AI agents: https://app.deepvalues.ai/developers?utm_source=podcast&utm_medium=description&utm_campaign=dvi&utm_content=jnj
Podcast: Apple Podcasts https://podcasts.apple.com/us/podcast/id1814712395
This episode is the AI-generated narrative summary (AI voice) of the Deep Value Intelligence report on Johnson & Johnson (JNJ) dated 2026-10-24.
Watch the videos on YouTube: https://www.youtube.com/@TheDeepValues
Disclaimer: The Deep Values channel and any related entity, including deepvalues.ai and DeepValueIntelligence, is an independent research and educational platform. We do not provide investment advisory, brokerage, financial planning, tax or legal services, and we are not registered as an investment adviser or fiduciary in any jurisdiction. All content — reports, analyses, tools, models and commentary — is for informational and educational purposes only and is not financial, investment, legal or tax advice, nor a recommendation or solicitation to buy or sell any security. Bullish / Neutral / Bearish are AI-generated research stances, not personal advice. Information is based on public sources believed to be reliable but is not guaranteed for accuracy or completeness and may change without notice. Investing involves risk, including loss of principal; past performance is not indicative of future results. You are solely responsible for your financial decisions. Consult a qualified licensed professional before making any investment decision.
